| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76394-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-34992-1mg | |||
| Carrier-Free | NBP2-34992-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Low Endotoxin, Azide and BSA Free | NB600-1443-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-33220 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| IHC-Prediluted | NBP2-45325 | |||
| Azide and BSA Free | NBP2-34588-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-25264 | |||
| Azide and BSA Free | NBP2-25264SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-86584-25ul | |||
![Western Blot: IL-33 Antibody [NBP1-76394] - Loading: 15ug of human lung lysate. Antibodies: IL-33, 2 g/mL , 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.](http://images.novusbio.com/fullsize/IL-33-Antibody-Western-Blot-NBP1-76394-img0011.jpg "Western Blot: IL-33 Antibody [NBP1-76394] - Loading: 15ug of human lung lysate. Antibodies: IL-33, 2 g/mL , 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.")
![Western Blot: IL-33 Antibody - BSA Free [NBP1-76394] - Validation of IL-33 in Human Lymph Node.Loading: 15. ug of human lymph node lysateAntibodies: IL-33, 2 ug/mL , 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.](http://images.novusbio.com/fullsize/nbp1-76394_rabbit-polyclonal-il-33-antibody-2711202420141963.gif)
![Western Blot: IL-33 Antibody [NBP1-76394] - Analysis of IL-33 in A-20 cell lysate with IL-33 antibody at (A) 1 and (B) 2 ug/mL.](http://images.novusbio.com/fullsize/IL-33-Antibody-Western-Blot-NBP1-76394-img0006.jpg)
![Western Blot: IL-33 Antibody [NBP1-76394] - Loading: 5ng (1) and 25ng (2) of IL-33 partial human recombinant protein.Antibodies: IL-33, NBP1-76394, 1 ug/mL , 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.Il-33 partial human recombinant protein: 112-270aa, 17.9kD, 36kD band is the dimer.](http://images.novusbio.com/fullsize/IL-33-Antibody-Western-Blot-NBP1-76394-img0008.jpg)
![<b>Biological Strategies Validation. </b>Western Blot: IL-33 Antibody [NBP1-76394] - Regulated Expression Validation of IL-33 in Human Skin Fibroblastsexpression of IL-33 in human skin fibroblasts following alpha-irradiation were detected by anti-IL-33 antibodies. IL-33 levels were increased after Alpha-irradiation, which were inhibited by treatment of PPP.](http://images.novusbio.com/fullsize/IL-33-Antibody-Western-Blot-NBP1-76394-img0009.jpg)
![Western Blot: IL-33 Antibody [NBP1-76394] - Human IL-33 has 4 isoforms, including isoform 1 (270aa, 30.8kD), isoform 2 (228aa, 25.9kD), isoform 3 (228aa, 26.1kD) and isoform 4 (144aa, 16.3kD). This antibody detects only human isoform L. Mouse IL-33 has 1 isoform (266aa, 30kD). Rat IL-33 has only one isoform identified so far (264aa, 29.5kD).](http://images.novusbio.com/fullsize/IL-33-Antibody-Western-Blot-NBP1-76394-img0010.jpg)
![Immunohistochemistry-Paraffin: IL-33 Antibody [NBP1-76394] - Analysis of of IL-33 in human lymph node tissue with IL-33 antibody at 2.5 ug/ml.](http://images.novusbio.com/fullsize/IL-33-Antibody-Immunohistochemistry-Paraffin-NBP1-76394-img0004.jpg)
![Immunocytochemistry/ Immunofluorescence: IL-33 Antibody - BSA Free [NBP1-76394] - Validation of IL-33 in Human Lymph Node.Immunofluorescent analysis of 4% paraformaldehyde-fixed human lymph node tissue labeling IL-33 with at 20 ug/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (red).](http://images.novusbio.com/fullsize/nbp1-76394_rabbit-polyclonal-il-33-antibody-2711202419381748.jpg)
![SDS-Page: Human IFN-gamma Protein [NBP2-34992]](http://images.novusbio.com/fullsize/Human-IFN-gamma-Protein-SDS-Page-NBP2-34992-img0001.jpg "SDS-Page: Human IFN-gamma Protein [NBP2-34992]")
![Immunocytochemistry/ Immunofluorescence: IL-12 Antibody [NB600-1443] - Irradiation inhibited IL-12 expression in tumors of hepatoma-bearing mice in vivo & DCs in vitro.HCa-1 & MIH-2 cells were injected intramuscularly into the right thighs of the mice, & tumors were irradiated with 10 Gy of radiation. Shown are IL-12 & DC (CD11c+) expressions at 1, 3, & 7 days after irradiation in (a) HCa-1 & (b) MIH-2 tumors & (c) IL-12 expression in the spleens of HCa-1 bearing mice (** P < 0.01). (d) IL-12 expression in BMDCs incubated with supernatant of MIH-2 tumor cells or supernatant of 10 Gy irradiating MIH-2 tumor cells. (** P < 0.01). DCs were differentiated from bone marrow of C3H/HeN normal mice (BMDCs). These were incubated for 72 h in supernatant of MIH-2 tumor cells with or without 10 Gy irradiation. IL-12 was intracellular stained with IL-12 antibody & analyzed by FACS. BMDCs also were stimulated with LPS (100 ng/mL) to allow maturation & irradiated with 10 Gy of radiation. (e) IL-12 expression (** P < 0.01), (f) cell viability, & (g) B7.1 expression in LPS stimulated BMDCs receiving 10 Gy radiation. (* P < 0.05). Data are from three independent experiments with five mice per group. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/26745884), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb600-1443_goat-polyclonal-il-12-antibody-31020241616187.jpg)
![Immunocytochemistry/ Immunofluorescence: IL-12 Antibody [NB600-1443] - Irradiation-induced IL-6 suppressed IL-12 expression in tumors of hepatoma-bearing mice in vivo & DCs in vitro.IL-6 & IL-12 were measured at 1, 3, & 7 days after 10 Gy irradiation of tumors. Shown are the expressions of IL-6 & IL-12 in (a) HCa-1 & (b) MIH-2 tumors (* P < 0.05). BMDCs were prepared from bone marrow of mice & stimulated with LPS. (c) IL-6 expression analyzed at the indicated times by ELISA in irradiated or non-irradiated BMDCs in vitro. (d) IL-6R (** P < 0.01, vs No IR) & (e) sIL6R (** P < 0.01) were evaluated at 2 day after 10 Gy irradiation to BMDCs by FACS & ELISA, respectively. BMDCs were treated without or with IL-6 (20 ng/mL) plus LPS. (f) Down regulation of IL-12 production by IL-6 treatment in BMDCs (** P < 0.01). BMDCs were stimulated with LPS for activation & cultured with or without anti-IL-6 antibody (final concentration of 500 ng/mL) during the indicated times after irradiation in vitro. IL-6 & IL-12 were analyzed by ELISA. (g) Recovery of IL-12 production & (h) B7-1/ B7-2 expression using an anti-IL-6 antibody in irradiated-BMDCs stimulated with LPS in vitro. (** P < 0.01, * P < 0.05). Data are from three independent experiments. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/26745884), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb600-1443_goat-polyclonal-il-12-antibody-310202416182614.jpg)
![Immunocytochemistry/ Immunofluorescence: IL-12 Antibody [NB600-1443] - Irradiation-induced IL-6 suppressed IL-12 expression in tumors of hepatoma-bearing mice in vivo & DCs in vitro.IL-6 & IL-12 were measured at 1, 3, & 7 days after 10 Gy irradiation of tumors. Shown are the expressions of IL-6 & IL-12 in (a) HCa-1 & (b) MIH-2 tumors (* P < 0.05). BMDCs were prepared from bone marrow of mice & stimulated with LPS. (c) IL-6 expression analyzed at the indicated times by ELISA in irradiated or non-irradiated BMDCs in vitro. (d) IL-6R (** P < 0.01, vs No IR) & (e) sIL6R (** P < 0.01) were evaluated at 2 day after 10 Gy irradiation to BMDCs by FACS & ELISA, respectively. BMDCs were treated without or with IL-6 (20 ng/mL) plus LPS. (f) Down regulation of IL-12 production by IL-6 treatment in BMDCs (** P < 0.01). BMDCs were stimulated with LPS for activation & cultured with or without anti-IL-6 antibody (final concentration of 500 ng/mL) during the indicated times after irradiation in vitro. IL-6 & IL-12 were analyzed by ELISA. (g) Recovery of IL-12 production & (h) B7-1/ B7-2 expression using an anti-IL-6 antibody in irradiated-BMDCs stimulated with LPS in vitro. (** P < 0.01, * P < 0.05). Data are from three independent experiments. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/26745884), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb600-1443_goat-polyclonal-il-12-antibody-310202416154619.jpg)
![Immunocytochemistry/ Immunofluorescence: IL-12 Antibody [NB600-1443] - Irradiation inhibited IL-12 expression in tumors of hepatoma-bearing mice in vivo & DCs in vitro.HCa-1 & MIH-2 cells were injected intramuscularly into the right thighs of the mice, & tumors were irradiated with 10 Gy of radiation. Shown are IL-12 & DC (CD11c+) expressions at 1, 3, & 7 days after irradiation in (a) HCa-1 & (b) MIH-2 tumors & (c) IL-12 expression in the spleens of HCa-1 bearing mice (** P < 0.01). (d) IL-12 expression in BMDCs incubated with supernatant of MIH-2 tumor cells or supernatant of 10 Gy irradiating MIH-2 tumor cells. (** P < 0.01). DCs were differentiated from bone marrow of C3H/HeN normal mice (BMDCs). These were incubated for 72 h in supernatant of MIH-2 tumor cells with or without 10 Gy irradiation. IL-12 was intracellular stained with IL-12 antibody & analyzed by FACS. BMDCs also were stimulated with LPS (100 ng/mL) to allow maturation & irradiated with 10 Gy of radiation. (e) IL-12 expression (** P < 0.01), (f) cell viability, & (g) B7.1 expression in LPS stimulated BMDCs receiving 10 Gy radiation. (* P < 0.05). Data are from three independent experiments with five mice per group. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/26745884), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb600-1443_goat-polyclonal-il-12-antibody-310202416163756.jpg)
![Western Blot: p62/SQSTM1 Antibody [NBP1-49954] - Human AC16 under normoxic and hypoxic conditions. WB image submitted by a verified customer review.](http://images.novusbio.com/fullsize/p62-SQSTM1-Antibody-Western-Blot-NBP1-49954-img0006.jpg "<b>Biological Strategies Validation. </b>Western Blot: p62/SQSTM1 Antibody [NBP1-49954] - Human AC16 under normoxic and hypoxic conditions. WB image submitted by a verified customer review.")
![<b>Biological Strategies Validation. </b>Immunohistochemistry-Paraffin: p62/SQSTM1 Antibody [NBP1-49954] - Sample: FFPE section of human breast carcinoma. Antibody: Affinity purified rabbit anti- Sequestosome-1 used at a dilution of 1:1,000 (1ug/ml). Detection: Vector Laboratories ImmPACT NovaRED Peroxidase Substrate](http://images.novusbio.com/fullsize/p62-SQSTM1-Antibody-Immunohistochemistry-NBP1-49954-img0005.jpg)
![<b>Independent Antibodies Validation and Biological Strategies Validation.</b>Western Blot: p62/SQSTM1 Antibody [NBP1-49954] - Detection of Human and Mouse Sequestosome-1 by Western Blot (h&m) and Immunoprecipitation (h). Samples: Whole cell lysate from HeLa (5, 15 and 50 mcg for WB; 1 mg for IP, 20% of IP loaded), 293T (T; 50 mcg), and mouse NIH3T3 (M; 50 mcg) cells. Antibodies: Affinity purified rabbit anti-Sequestosome-1 antibody used for WB at 0.1 mcg/ml (A) and 0.4 mcg/ml (B) and used for IP at 3 mcg/mg lysate. Sequestosome-1 was also immunoprecipitated by rabbit anti-Sequestosome-1 antibodies which recognize downstream epitopes. For blotting immunoprecipitated Sequestosome-1 was used. Detection: Chemiluminescence with exposure times of 30 seconds (A) and 3 seconds (B).](http://images.novusbio.com/fullsize/p62-SQSTM1-Antibody-Western-Blot-NBP1-49954-img0004.jpg)
![Simple Western: p62/SQSTM1 Antibody [NBP1-49954] - Simple Western lane view shows a specific band for p62/SQSTM1 in 0.5 mg/ml of HeLa lysate. This experiment was performed under reducing conditions using the 12-230 kDa separation system.](http://images.novusbio.com/fullsize/p62-SQSTM1-Antibody-Simple-Western-NBP1-49954-img0003.jpg)
![Immunohistochemistry-Paraffin: IL-2 Antibody [NBP2-16948] - Human tonsil. Image from verified customer review.](http://images.novusbio.com/fullsize/IL-2-Antibody-Immunohistochemistry-Paraffin-NBP2-16948-img0006.jpg "Immunohistochemistry-Paraffin: IL-2 Antibody [NBP2-16948] - Human tonsil. Image from verified customer review.")
![Flow Cytometry: IL-2 Antibody [NBP2-16948] - THP-1 cell. Black: Unlabelled sample was used as a control. Red: IL2 antibody dilution: 1:50. Acquisition of 20,000 events were collected for FACS analysis.](http://images.novusbio.com/fullsize/IL-2-Antibody-Flow-Cytometry-NBP2-16948-img0007.jpg)
![Immunohistochemistry-Paraffin: IL-2 Antibody [NBP2-16948] - Human gastric cancer, using IL2 antibody at 1:500 dilution. Antigen Retrieval: Trilogy™ (EDTA based, pH 8.0) buffer, 15min.](http://images.novusbio.com/fullsize/IL-2-Antibody-Immunohistochemistry-Paraffin-NBP2-16948-img0004.jpg)
![Western Blot: IKK gamma Antibody (46B844) [NB100-56532] - Analysis using NEMO (IKKgamma) antibody. Lysate from human Jurkat cells probed with NEMO antibody at 2 ug/ml. The goat anti-mouse IgG1 HRP secondary and PicoTect ECL substrate solution were used for this test.](http://images.novusbio.com/fullsize/IKK-gamma-Antibody-46B844-Western-Blot-NB100-56532-img0007.jpg "Western Blot: IKK gamma Antibody (46B844) [NB100-56532] - Analysis using NEMO (IKKgamma) antibody. Lysate from human Jurkat cells probed with NEMO antibody at 2 ug/ml. The goat anti-mouse IgG1 HRP secondary and PicoTect ECL substrate solution were used for this test.")
![Flow Cytometry: IKK gamma Antibody (46B844) [NB100-56532] - Human Jurkat cells were probed using 0.1 ug of NEMO antibody (red) and 0.1 ug of isotype control (green), with shaded histogram representing cells alone and an anti-mouse IgG-FITC secondary antibody.](http://images.novusbio.com/fullsize/IKK-gamma-Antibody-46B844-Flow-Cytometry-NB100-56532-img0005.jpg)
![Immunohistochemistry-Paraffin: CD8 Antibody (C8/144B) [NBP2-32836] - Formalin-fixed, paraffin-embedded human Tonsil stained with CD8 Antibody (C8/144B).](http://images.novusbio.com/fullsize/CD8-Antibody-C8-144B-Immunohistochemistry-Paraffin-NBP2-32836-img0003.jpg "Immunohistochemistry-Paraffin: CD8 Antibody (C8/144B) [NBP2-32836] - Formalin-fixed, paraffin-embedded human Tonsil stained with CD8 Antibody (C8/144B).")
![Immunohistochemistry-Paraffin: CD8 Antibody (C8/144B) [NBP2-32836] - Formalin-fixed, paraffin-embedded human Tonsil stained with CD8 Antibody (C8/144B).](http://images.novusbio.com/fullsize/CD8-Antibody-C8-144B-Immunohistochemistry-Paraffin-NBP2-32836-img0002.jpg)
![Western Blot: IL-7 R alpha/CD127 Antibody (73N8F2) [NBP2-25249] - Analysis of (A) IL-17R recombinant protein fragment and (B) mouse thymus lysate using IL-7R antibody at 2 ug/ml.](http://images.novusbio.com/fullsize/IL-7-R-alpha-CD127-Antibody-73N8F2-Western-Blot-NBP2-25249-img0005.jpg "Western Blot: IL-7 R alpha/CD127 Antibody (73N8F2) [NBP2-25249] - Analysis of (A) IL-17R recombinant protein fragment and (B) mouse thymus lysate using IL-7R antibody at 2 ug/ml.")
![Immunohistochemistry-Paraffin: IL-7 R alpha/CD127 Antibody (73N8F2) [NBP2-25249] - Mouse testis stained with IL-7R antibody at 5 ug/ml.](http://images.novusbio.com/fullsize/IL-7-R-alpha-CD127-Antibody-73N8F2-Immunohistochemistry-Paraffin-NBP2-25249-img0004.jpg)
![Immunoprecipitation: CD4 Antibody (BL-155-1C11) [NBP2-76423] - Detection of human CD4 by WB of immunoprecipitates from MOLT-4 lysate. Antibodies: Rabbit anti-CD4 recombinant monoclonal [BL-155-1C11] (NBP2-76423) and another rabbit anti-CD4 antibody.](http://images.novusbio.com/fullsize/CD4-Antibody-BL-155-1C11-Immunoprecipitation-NBP2-76423-img0003.jpg "<b>Independent Antibodies Validation. </b>Immunoprecipitation: CD4 Antibody (BL-155-1C11) [NBP2-76423] - Detection of human CD4 by WB of immunoprecipitates from MOLT-4 lysate. Antibodies: Rabbit anti-CD4 recombinant monoclonal [BL-155-1C11] (NBP2-76423) and another rabbit anti-CD4 antibody.")
![<b>Independent Antibodies Validation. </b>Western Blot: CD4 Antibody (BL-155-1C11) [NBP2-76423] - Whole cell lysate (10 ug) from U-937, HEK293T, MOLT-4, HeLa, and Jurkat cells prepared using NETN lysis buffer. Antibody: Rabbit anti-CD4 recombinant monoclonal antibody [BL-155-1C11] used at 1:1000. Secondary: HRP-conjugated goat anti-rabbit IgG. Chemiluminescence with an exposure time of 75 seconds. Lower Panel: Rabbit anti-Actin recombinant monoclonal antibody [BLR057F].](http://images.novusbio.com/fullsize/nbp2-76423_rabbit-monoclonal-cd4-antibody-bl-155-1c11-western-blot-272202465128..jpg)
![Flow Cytometry- CD4 Antibody (BL-155-1C11) [NBP2-76423] -Rabbit anti-CD4 recombinantmonoclonal [BL-155-1C11] or isotype control (unshaded). Secondary: DyLight® 488-conjugated goatanti-rabbit IgG.](http://images.novusbio.com/fullsize/nbp2-76423_rabbit-monoclonal-cd4-antibody-bl-155-1c11-flow-cytometry-27220246544..jpg)
![Immunohistochemistry-Paraffin: CD4 Antibody (BL-155-1C11) [NBP2-76423] -Rabbit anti-CD4 recombinant monoclonal antibody[BL-155-1C11]. Secondary: HRP conjugated goat anti-rabbit IgG. Substrate: DAB.](http://images.novusbio.com/fullsize/nbp2-76423_rabbit-monoclonal-cd4-antibody-bl-155-1c11-immunohistochemistry-paraffin-272202465557..jpg)
![Immunohistochemistry-Paraffin: CCR4 Antibody [NBP1-86584] - Staining of human cerebral cortex shows no positivity in neurons as expected.](http://images.novusbio.com/fullsize/CCR4-Antibody-Immunohistochemistry-Paraffin-NBP1-86584-img0014.jpg "<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: CCR4 Antibody [NBP1-86584] - Staining of human cerebral cortex shows no positivity in neurons as expected.")
![<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: CCR4 Antibody [NBP1-86584] - Staining of human rectum shows strong cytoplasmic positivity in lymphoid cells.](http://images.novusbio.com/fullsize/CCR4-Antibody-Immunohistochemistry-Paraffin-NBP1-86584-img0011.jpg)
![Immunohistochemistry-Paraffin: CCR4 Antibody [NBP1-86584] - Staining of human skeletal muscle shows no positivity in striated muscle fibers, as expected.](http://images.novusbio.com/fullsize/CCR4-Antibody-Immunohistochemistry-Paraffin-NBP1-86584-img0012.jpg)
![Immunohistochemistry-Paraffin: CCR4 Antibody [NBP1-86584] - Staining of human tonsil shows moderate to strong cytoplasmic positivity in a subset of lymphoid cells.](http://images.novusbio.com/fullsize/CCR4-Antibody-Immunohistochemistry-Paraffin-NBP1-86584-img0013.jpg)
![Flow Cytometry: CD3 epsilon Antibody (APA1/1) [NBP1-30426] - Intracellular staining of JURKAT cells with anti-CD3 epsilon activation epitope (APA1/1) PE.](http://images.novusbio.com/fullsize/CD3-epsilon-Antibody-APA1-1-Flow-Cytometry-NBP1-30426-img0002.jpg "Flow Cytometry: CD3 epsilon Antibody (APA1/1) [NBP1-30426] - Intracellular staining of JURKAT cells with anti-CD3 epsilon activation epitope (APA1/1) PE.")
![Flow Cytometry: CD3 epsilon Antibody (APA1/1) [NBP1-30426] - Intracellular staining of human peripheral blood with anti-CD3 epsilon activation epitope (APA1/1) purified, GAM-FITC.](http://images.novusbio.com/fullsize/CD3-epsilon-Antibody-APA1-1-Flow-Cytometry-NBP1-30426-img0001.jpg)
![Immunohistochemistry-Paraffin: Histamine H4R Antibody [NLS3775] - Lung, Non Small-Cell Carcinoma](http://images.novusbio.com/fullsize/Histamine-H4R-Antibody-Immunohistochemistry-Paraffin-NLS3775-img0006.jpg "Immunohistochemistry-Paraffin: Histamine H4R Antibody [NLS3775] - Lung, Non Small-Cell Carcinoma")
![Immunohistochemistry-Paraffin: Histamine H4 R Antibody [NLS3775] - IHC analysis of Lymph node using this antibody at 12 ug/ ml.](http://images.novusbio.com/fullsize/Histamine-H4-R-Antibody-Immunohistochemistry-Paraffin-NLS3775-img0001.jpg)
![Immunohistochemistry-Paraffin: Histamine H4 R Antibody [NLS3775] - Anti-HRH4 / Histamine H4 Receptor antibody IHC of human Ovary, Carcinoma and Inflammatory Cells. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval.](http://images.novusbio.com/fullsize/Histamine-H4-R-Antibody-Immunohistochemistry-Paraffin-NLS3775-img0002.jpg)
![Immunohistochemistry-Paraffin: Histamine H4R Antibody [NLS3775] - Ovary, carcinoma](http://images.novusbio.com/fullsize/Histamine-H4R-Antibody-Immunohistochemistry-Paraffin-NLS3775-img0003.jpg)
![Immunohistochemistry-Paraffin: Histamine H4R Antibody [NLS3775] - Pancreas, carcinoma](http://images.novusbio.com/fullsize/Histamine-H4R-Antibody-Immunohistochemistry-Paraffin-NLS3775-img0004.jpg)
![Immunohistochemistry-Paraffin: Histamine H4R Antibody [NLS3775] - Colon, Carcinoma](http://images.novusbio.com/fullsize/Histamine-H4R-Antibody-Immunohistochemistry-Paraffin-NLS3775-img0005.jpg)
![Immunohistochemistry-Paraffin: Histamine H4R Antibody - BSA Free [NLS3775] - Immunohistochemistry of formalin-fixed, paraffin-embedded Human Testis, Mast Cells tissue](http://images.novusbio.com/fullsize/nls3775_rabbit-histamine-h4r-pab-bsa-free-10920241111286.jpg)
